JP2014240389A5 - - Google Patents

Download PDF

Info

Publication number
JP2014240389A5
JP2014240389A5 JP2014130313A JP2014130313A JP2014240389A5 JP 2014240389 A5 JP2014240389 A5 JP 2014240389A5 JP 2014130313 A JP2014130313 A JP 2014130313A JP 2014130313 A JP2014130313 A JP 2014130313A JP 2014240389 A5 JP2014240389 A5 JP 2014240389A5
Authority
JP
Japan
Prior art keywords
seq
group
skin
cosmetic composition
kallikrein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014130313A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014240389A (ja
JP5891266B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014240389A publication Critical patent/JP2014240389A/ja
Publication of JP2014240389A5 publication Critical patent/JP2014240389A5/ja
Application granted granted Critical
Publication of JP5891266B2 publication Critical patent/JP5891266B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014130313A 2008-01-21 2014-06-25 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用 Expired - Fee Related JP5891266B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2238608P 2008-01-21 2008-01-21
US61/022,386 2008-01-21
US657608P 2008-01-22 2008-01-22
US61/006,576 2008-01-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010542703A Division JP5615184B2 (ja) 2008-01-21 2009-01-21 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用

Publications (3)

Publication Number Publication Date
JP2014240389A JP2014240389A (ja) 2014-12-25
JP2014240389A5 true JP2014240389A5 (enExample) 2015-02-12
JP5891266B2 JP5891266B2 (ja) 2016-03-22

Family

ID=40901490

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010542703A Expired - Fee Related JP5615184B2 (ja) 2008-01-21 2009-01-21 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用
JP2014130313A Expired - Fee Related JP5891266B2 (ja) 2008-01-21 2014-06-25 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010542703A Expired - Fee Related JP5615184B2 (ja) 2008-01-21 2009-01-21 皮膚病の治療におけるセリンプロテアーゼ阻害剤の使用

Country Status (8)

Country Link
US (3) US20110130338A1 (enExample)
EP (1) EP2244728B1 (enExample)
JP (2) JP5615184B2 (enExample)
CN (2) CN101977626A (enExample)
AU (1) AU2009207394B2 (enExample)
BR (1) BRPI0906167A2 (enExample)
CA (1) CA2712512C (enExample)
WO (1) WO2009093119A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101977626A (zh) 2008-01-21 2011-02-16 德莫迪斯公司 丝氨酸蛋白酶抑制剂在治疗皮肤病中的用途
WO2010103475A2 (en) * 2009-03-10 2010-09-16 Med Discovery Sa Use of serine protease inhibitors in the treatment of neutropenia
KR101979464B1 (ko) 2011-12-09 2019-05-16 모멘티브 파포만스 마테리아루즈 쟈판 고도가이샤 실리콘 고무 발포체용 조성물, 실리콘 고무 발포체의 제조방법 및 실리콘 고무 발포체
TW201410709A (zh) * 2012-08-08 2014-03-16 Daiichi Sankyo Co Ltd 肽庫及其利用
US9815878B2 (en) 2012-09-19 2017-11-14 Mackay Memorial Hospital Use of PEDF-derived polypeptides for preventing and/or ameliorating skin aging
KR101437408B1 (ko) 2012-11-05 2014-09-05 동아대학교 산학협력단 플라스민 및 엘라스타아제 저해 활성을 갖는 산왕거미 유래의 쿠니츠 타입 세린 프로테아제 저해 단백질 및 이를 유효성분으로 포함하는 염증 억제 및 항섬유소용해용 조성물
US10807805B2 (en) 2013-05-17 2020-10-20 Intelligrated Headquarters, Llc Robotic carton unloader
CN105473474B (zh) 2013-05-17 2018-01-23 因特利格兰特总部有限责任公司 机器人纸箱卸载机
GB201322091D0 (en) * 2013-12-13 2014-01-29 Cambridge Entpr Ltd Modified serpins for the treatment of bleeding disorders
WO2015114144A1 (en) * 2014-02-03 2015-08-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of netherton syndrome
JP6608382B2 (ja) * 2014-02-26 2019-11-20 ルマ セラピューティクス,インク. 紫外光治療装置及び方法
JP6738280B2 (ja) * 2014-10-24 2020-08-12 株式会社 資生堂 角層剥離の抑制又は亢進に起因する肌状態を改善するための美容方法及び評価方法
MA40998A (fr) 2014-11-21 2017-09-26 Ophirex Inc Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés
US10597235B2 (en) 2016-10-20 2020-03-24 Intelligrated Headquarters, Llc Carton unloader tool for jam recovery
CN106478812B (zh) * 2016-10-21 2020-11-20 沈阳药科大学 丝氨酸蛋白酶抑制剂-3及其功能、制备方法和应用
TW202313978A (zh) * 2016-11-23 2023-04-01 美商阿尼拉製藥公司 絲胺酸蛋白酶抑制因子A1 iRNA組成物及其使用方法
EP3624820A1 (en) * 2017-04-21 2020-03-25 H. Hoffnabb-La Roche Ag Use of klk5 antagonists for treatment of a disease
CA3067364A1 (en) * 2017-06-16 2018-12-20 Azitra Inc Compositions and methods for treatment of netherton syndrome with lekti expressing recombinant microbes
US20200040103A1 (en) 2018-03-14 2020-02-06 Genentech, Inc. Anti-klk5 antibodies and methods of use
JP7562515B2 (ja) * 2018-09-24 2024-10-07 クリスタル バイオテック インコーポレイテッド ネザートン症候群の治療のための組成物及び方法
CR20220156A (es) 2019-09-18 2022-05-23 Genentech Inc Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5/klk7 y métodos de uso
WO2021102176A2 (en) * 2019-11-21 2021-05-27 The Regents Of The University Of Michigan Polypeptide inhibitors of neutrophil elastase activity and uses thereof
EP4114414A4 (en) * 2020-03-06 2024-03-27 The Regents of The University of Michigan Serine protease inhibitors for suppressing or preventing anaphylactic reaction
CN112315897A (zh) * 2020-11-04 2021-02-05 深圳前海鹰岗生物科技有限公司 一种抑制细胞炎症反应释放治疗痛风急性发作的聚合物微针及制备方法
EP4466008A4 (en) * 2022-01-18 2025-08-20 Univ California METHOD FOR INHIBITING PROTEASE ACTIVITY IN DEGRADATION DURING AGING
WO2024159008A1 (en) * 2023-01-25 2024-08-02 Quoin Pharmaceuticals, Inc. Combination treatment for netherton syndrome
CN117084936A (zh) * 2023-09-22 2023-11-21 南京盛德生物科技研究院有限公司 多萜类化合物作为激肽释放酶抑制剂在化妆品中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079336A (en) * 1989-06-23 1992-01-07 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5252725A (en) * 1989-06-23 1993-10-12 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
PT1202743E (pt) * 1999-06-18 2005-02-28 Jon Bragi Bjarnason Composicoes farmaceuticas e cosmeticas compreendendo serina-proteases de bacalhau e sua utilizacao farmaceutica e cosmetica
US7105172B1 (en) * 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
EP1334179A2 (en) * 2000-11-14 2003-08-13 Bristol-Myers Squibb Company A human serpin secreted from lymphoid cells lsi-01
JP2006508971A (ja) * 2002-11-20 2006-03-16 アライバ−プロメティック インコーポレイティド プロテアーゼ阻害剤を使用して炎症性疾患を治療する組成物及び方法
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation
CN1798838B (zh) * 2003-04-04 2012-01-04 洛桑大学 一种蛋白酶的抑制剂蛋白及其用途
WO2005117955A1 (en) * 2004-05-19 2005-12-15 Arriva Pharmaceuticals, Inc. Treatment of atopic dermatitis with unglycosylated alpha one-antitrypsin
EP1666075A1 (en) * 2004-10-04 2006-06-07 Switch Biotech Aktiengesellschaft Wound dressing compositions, especially for delivery of protease inhibitors
WO2006090282A2 (en) * 2005-02-28 2006-08-31 Universite De Lausanne Recombinant inhibitor proteins of an hk14 protease and use thereof
GB0525999D0 (en) * 2005-12-21 2006-02-01 Ares Trading Sa Novel members of the kazal family of serine protease inhibitors
UA98647C2 (en) * 2007-06-28 2012-06-11 Новартис Аг Kallikrein-7 modulators
JP5401459B2 (ja) * 2007-08-17 2014-01-29 ノバルティス アーゲー カリクレイン7を阻害するための環状デプシペプチドの使用
CN101977626A (zh) 2008-01-21 2011-02-16 德莫迪斯公司 丝氨酸蛋白酶抑制剂在治疗皮肤病中的用途

Similar Documents

Publication Publication Date Title
JP2014240389A5 (enExample)
Levin et al. Next generation matrix metalloproteinase inhibitors—Novel strategies bring new prospects
Heutinck et al. Serine proteases of the human immune system in health and disease
EP3623470A3 (en) Factor ix variants with clotting activity in absence of their cofactor and their use for treating bleeding disorders
WO2011150284A3 (en) Removal of serine proteases by treatment with finely divided silicon dioxide
EA201291367A1 (ru) Удаление сериновых протеаз путем обработки тонкоизмельченным диоксидом кремния
NO20082044L (no) Kombinasjonsterapi innbefattende substituerte oksazolidinoner for prevensjon og behandling av cerebrale kretslopssykdommer
ECSP045115A (es) INDOL-2-CARBOXAMIDAS COMO INHIBIDORES DEL FACTOR Xa
TW200724157A (en) A non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
JP2017518370A5 (enExample)
WO2013061083A3 (en) Therapeutic agents and uses thereof
MY183252A (en) Kallirein 7 modulators
WO2020186132A8 (en) Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
TN2009000503A1 (en) Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
CY1107342T1 (el) Χρηση παραγωγων νιτριλιου ως φαρμακο
MXPA05012675A (es) Compuestos de hidroxiamidina e hidroxiguanidina como inhibidores de urocinasa.
WO2009136997A3 (en) Inhibitors of human cathepsin l, cathepsin b, and cathepsin s
WO2007117559A3 (en) Renin inhibitors
MY157366A (en) Therapies and compositions comprising cathepsin s antibodies
WO2007099348A3 (en) Cathepsin propeptide and uses thereof
WO2007132292A3 (en) Therapy for alzheimer's disease
WO2005074904A3 (en) Silinane compounds as cysteine protease inhibitors
WO2020023094A3 (en) Treatment of lysosomal storage disorders
ZA200908583B (en) Substituted (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides and use thereof in the field of blood coagulation
ATE410174T1 (de) Zusammensetzung zur vorbeugung und behandlung von erkältungskrankheiten